Surrozen, Inc./DE Earnings Per Share (Basic)
Surrozen, Inc./DE (SRZN) reported Earnings Per Share (Basic) of $2.75 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Surrozen, Inc./DE earnings per share, basic for the quarter ending 2026-06-30 was $2.75, a 7.84% increase year-over-year.
- Surrozen, Inc./DE earnings per share, basic for the quarter ending 2026-03-31 was -$11.65.
- Surrozen, Inc./DE earnings per share, basic for the quarter ending 2025-09-30 was -$8.36.
- Surrozen, Inc./DE earnings per share, basic for the quarter ending 2025-06-30 was $2.55.
- Surrozen, Inc./DE earnings per share, basic for fiscal 2025 was -$32.37.
- Surrozen, Inc./DE earnings per share, basic for fiscal 2024 was -$21.67.
- Surrozen, Inc./DE earnings per share, basic for fiscal 2023 was -$21.33.
- Surrozen, Inc./DE earnings per share, basic for fiscal 2022 was -$15.56.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.75 10-Q · filed 2026-08-06 | -$6.84 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | -$11.65 10-Q · filed 2026-05-06 | |||||||
| 2025-12-31 | -$32.37 10-K · filed 2026-03-23 | |||||||
| 2025-09-30 | -$8.36 10-Q · filed 2025-11-07 | -$11.66 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$8.49 10-Q · filed 2025-11-07 | |||||
| 2025-06-30 | $2.55 10-Q · filed 2026-08-06 | $0.85 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | -$7.43 10-Q · filed 2026-05-06 | |||||||
| 2024-12-31 | -$21.67 10-K · filed 2026-03-23 | |||||||
| 2024-09-30 | -$0.44 10-Q · filed 2025-11-07 | -$8355.24 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$12.57 10-Q · filed 2025-11-07 | |||||
| 2024-06-30 | -$7.99 10-Q · filed 2025-08-08 | -$13.00 10-Q · filed 2025-08-08 | ||||||
| 2024-03-31 | -$4.24 10-Q · filed 2025-05-09 | |||||||
| 2023-12-31 | -$21.33 10-K · filed 2025-03-31 | |||||||
| 2023-09-30 | -$5.14 10-Q · filed 2024-11-06 | -$0.34 10-Q · filed 2023-11-08 | -$16.96 10-Q · filed 2024-11-06 | -$1.13 10-Q · filed 2023-11-08 | ||||
| 2023-06-30 | -$4.68 10-Q · filed 2024-08-12 | -$0.31 10-Q · filed 2023-08-09 | -$11.84 10-Q · filed 2024-08-12 | -$0.79 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | -$7.16 10-Q · filed 2024-05-08 | -$0.48 10-Q · filed 2023-05-10 | ||||||
| 2022-12-31 | -$15.56 10-K · filed 2024-04-10 | -$1.04 10-K · filed 2023-03-31 | ||||||
| 2022-09-30 | -$0.38 10-Q · filed 2023-11-08 | -$1.01 10-Q · filed 2023-11-08 | ||||||
| 2022-06-30 | -$0.40 10-Q · filed 2023-08-09 | -$0.63 10-Q · filed 2023-08-09 | ||||||
| 2022-03-31 | -$0.23 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | -$2.21 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | -$0.51 10-Q · filed 2022-11-14 | -$1.86 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.69 10-Q · filed 2022-08-11 | -$1.41 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |